TEVA PHARMACEUTICAL INDUSTRIES LTD·4

Sep 5, 4:05 PM ET

Shalev Varda 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Sep 5, 2023

Insider Transaction Report

Form 4
Period: 2023-09-02
Shalev Varda
Director
Transactions
  • Award

    Restricted Share Units

    2023-09-02+12,87212,872 total
    Ordinary Shares (12,872 underlying)
Footnotes (3)
  • [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F2]Restricted share units were granted on September 2, 2023 and vest on September 2, 2024.
  • [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION